Humatrope (Somatropin rDNA Origin) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - December 15, 2016 Category: Drugs & Pharmacology Source Type: news
Omnitrope (Somatropin [ rDNA origin] Injection) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - October 31, 2016 Category: Drugs & Pharmacology Source Type: news
Zorbtive (Somatropin rDNA Origin for Injection) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - March 14, 2016 Category: Drugs & Pharmacology Source Type: news
Government restores customs duty exemption on three drugs
The Central Board of Excise and Customs (CBEC) in a notification restored import duty exemption on three drugs -- Octreotide, Somatropin and Anti- Haemophilic Factor Concentrate (VIII and IX). (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - February 17, 2016 Category: Pharmaceuticals Source Type: news
Zomacton (somatropin rDNA origin) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - July 2, 2015 Category: Drugs & Pharmacology Source Type: news
Ferring Pharmaceuticals Receives FDA Approval for Growth Hormone Name Change, Acquires Zomacton [somatropin (rDNA origin)]
PARSIPPANY, N.J., March 31, 2015 – Ferring Pharmaceuticals Inc. today announced U.S. Food and Drug Administration (FDA) approval of a name change enabling its newly acquired recombinant human growth hormone to be marketed in the U.S. as Zomacton... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 1, 2015 Category: Pharmaceuticals Source Type: news
Genotropin (Somatropin [rDNA origin]) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - October 27, 2014 Category: Drugs & Pharmacology Source Type: news
Oncology Leads Biosimilars Market Growth to 2018 Forecasts in New...
RnRMarketResearch.com adds “Biosimilars Market Product [Recombinant Non-Glycosylated Proteins (Insulin, Filgrastim, Somatropin), Glycosylated (Monoclonal Antibodies, Erythropoietin), Peptides...(PRWeb December 05, 2013)Read the full story at http://www.prweb.com/releases/2018-biosimilars-market/market-report/prweb11395443.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - December 6, 2013 Category: Pharmaceuticals Source Type: news
CHMP positive opinion regarding Somatropin Biopartners
Biopartners GmbH, a wholly owned subsidiary of Bioton SA, Poland, has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has issued a positive opinion regarding the approval of once-weekly Somatropin Biopartners for the treatment of growth hormone deficiency (GHD) in paediatric and adult patients. (Source: Pharmacy Europe)
Source: Pharmacy Europe - June 4, 2013 Category: Drugs & Pharmacology Source Type: news
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 27-30 May 2013 (EMA press release, 31 May 2013)
The European Medicines Agency (EMA) has published the latest news from its Committee for Medicinal Products for Human Use, including updates on Somatropin Biopartners for endogenous growth hormone deficiency, its review of new safety data on insulin glargine, an application to modify the approved use of Lysodren (mitotane) and a Q&A on withdrawal of the marketing authorisation application for
Belviq (lorcaserin).
Full article (Source: Society for Endocrinology)
Source: Society for Endocrinology - June 3, 2013 Category: Endocrinology Source Type: news
EMA Gives Nod to New Growth Hormone, Somatropin BiopartnersEMA Gives Nod to New Growth Hormone, Somatropin Biopartners
The EMA has issued a positive opinion for a new recombinant human growth hormone, Somatropin Biopartners. Formal approval normally follows after 67 days. Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 31, 2013 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news
Study of Omnitrope in Children Requiring GH TreatmentStudy of Omnitrope in Children Requiring GH Treatment
What does postmarketing surveillance tell us about safety and efficacy of somatropin for growth disturbances? Therapeutic Advances in Endocrinology and Metabolism (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 25, 2013 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news
